Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Aims: We explored changes in body weight, cardiometabolic and endocrine parameters in obese women with PCOS who continued treatment with metformin 2 years after discontinuation of short-term intervention with semaglutide
Fonseca VA
H2-receptor antagonist in the prevention of acute gastrointestinal hemorrhage in fulminant hepatic failure: a controlled trial
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine, 379(19), 1837-1847
US$ 24.98
US$ 27.72
US$ 24.75
US$ 26.20
US$ 26.12
US$ 29.79
US$ 22.80
US$ 24.41
US$ 24.46
US$ 24.10
